Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry...

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• A novel human nuclear receptor interaction protein (NRIP) was recently discovered.
• NRIP may enhance the transcriptional activity of steroid nuclear receptors.
• The biological functions and clinical implications of NRIP are not fully understood.

Purpose of the Study:

• To determine the distribution of NRIP expression in various malignant tumors and healthy tissues.
• To identify cell types expressing NRIP in cancer and normal tissues.
• To explore the physiological roles of NRIP in healthy and tumor cells.

Main Methods:

• Tissue microarray (TMA) technology was employed.
• An anti-NRIP monoclonal antibody immunohistochemical (IHC) survey was conducted.
• NRIP expression was examined in 48 tumor types and 48 control non-neoplastic tissues.

Main Results:

• NRIP expression was detected in six malignancies: esophageal, colon, breast, ovarian, skin, and pancreatic cancers.
• NRIP was not consistently expressed across all positive tumor types.
• Malignant tumors of the stomach, prostate, liver, lung, kidney, uterine cervix, urinary bladder, lymph node, testis, and tongue showed no NRIP expression.
• All control non-neoplastic tissues had IHC scores below the threshold.
• NRIP expression was significantly increased in carcinoma tissues compared to matched healthy tissues.

Conclusions:

• This is the first study to validate NRIP nuclear localization using human TMA and IHC.
• NRIP expression shows 23% sensitivity and 100% specificity for human malignancies.
• A significant difference in NRIP expression exists between primary carcinomatous tissues and matched healthy tissues.
• NRIP may serve as a potential diagnostic tool or adjunct for cancer diagnosis.
• Further large-scale studies are warranted to evaluate NRIP's role in cancer diagnosis and its biological functions.